Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 596 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07677358RecruitingPhase 1
Atirmociclib in people with normal or reduced liver function
This study tests how the body handles the medicine Atirmociclib in people with different levels of liver function, from normal to moderate or severe liver disease. It helps doctors understand if the dose needs to be adjusted for people with liver problems.
Miami Lakes, FloridaAges 18 years+ - NCT07672119Recruiting
Heart risks in older men on enzalutamide or darolutamide
This study looks at heart-related risks in older men with advanced prostate cancer who are taking enzalutamide or darolutamide. It may help doctors better understand how to manage heart health during treatment.
Whippany, New JerseyAges 55 years+ - NCT06211218Recruiting
AI screening for multiple corneal diseases
This study uses artificial intelligence to look at slit-lamp images of your eye to screen for different corneal diseases. It may help find problems early when they are easier to treat.
Tianjin, Tianjin MunicipalityAges Any age - NCT07669974Recruiting
Comparing two training methods for robot-assisted prostate surgery
This trial tests two training methods for learning robot-assisted radical prostatectomy (a surgery to remove the prostate using robotic tools). If you are a surgeon taking a specific training course, you may be able to join and help find out which teaching approach works best.
Melle, BelgiumAges Any age - NCT07662148RecruitingPhase 1
Testing the safety of BIIB144 in healthy adults
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
Las Vegas, NevadaAges 18–55 - NCT07660198RecruitingPhase 3
Pneumonia vaccine catch-up study for kids and teens
This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.
Birmingham, AlabamaAges 1.3 years–17 years - NCT07660731RecruitingPhase 1
Safety study of an experimental asthma medicine
This study tests an experimental medicine (PF-08103402) to see how well it is tolerated and how it acts in the body, in healthy adults and in people with mild-to-moderate asthma. Participation may help researchers learn if this treatment could help manage asthma symptoms.
New Haven, ConnecticutAges 18–65 - NCT07661433Recruiting
Testing an AI tool to estimate baby weight before birth
This trial tests whether an artificial intelligence (AI) tool can more accurately estimate a baby's weight using ultrasound, compared to standard methods. If you're about to give birth, this study may help improve how doctors predict your baby's size.
New Orleans, LouisianaAges 18 years+ - NCT06669884Recruiting
New ECG method to quickly sort chest pain in ER
This study tests a new ECG-based technology that may help doctors more quickly sort out the cause of your chest pain in the emergency room. If you have chest pain that needs checking, this tool could help decide how urgent your care is.
Jinan, ShandongAges 18 years+ - NCT07652723RecruitingPhase 1
How a new blood-clotting drug affects clotting with and without aspirin
This study tests an experimental drug (BAY3389934) to see how it affects blood clotting and if it's safe. It is given to healthy adults, alone and then with aspirin. It will help researchers understand how the drug works before testing in patients.
Miami, FloridaAges 18–55 - NCT05746260Recruiting
Testing sleep timing to improve arm learning after stroke
This study looks at how sleep may affect how well people relearn arm movements after a stroke. If you’re within a month of a stroke that affected your arm, your participation could help researchers understand better ways to support recovery.
OxfordAges 18 years+ - NCT07629440RecruitingPhase 3
New Pneumococcal Vaccine Study for Infants
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
Bessemer, AlabamaAges 1 month–7 months - NCT07620873Recruiting
Virtual Reality Education Before Kidney Stone Surgery
This study tests whether using virtual reality to learn about your upcoming kidney stone surgery can reduce anxiety and help you feel more prepared. You'll use a VR headset before your procedure to see what to expect.
KeelungAges 18 years+ - NCT07620119Recruiting
AI-assisted heart attack diagnosis in patients with LBBB
This study tests whether artificial intelligence can help doctors more accurately diagnose heart attacks in patients who have a specific heart rhythm pattern called Left Bundle Branch Block (LBBB). The goal is to improve emergency care by reducing delays in identifying who needs urgent treatment.
Konya, KaratayAges 18 years+ - NCT07618416Recruiting
Blood Pressure Prediction Before Anesthesia in Older Adults
This study tests a computer model that uses heart-rhythm measurements to predict whether your blood pressure will drop dangerously after anesthesia begins. If accurate, it could help doctors prepare and protect you during surgery.
Beijing, ChinaAges 65 years+ - NCT07609914RecruitingPhase 4
Safety study of an extra dose of rimegepant for migraine
This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.
Canoga Park, CaliforniaAges 18 years+ - NCT07611838Recruiting
Predicting ABPA Recurrence Using Blood and Immune Markers
This study helps doctors predict whether allergic bronchopulmonary aspergillosis (ABPA)—a serious lung condition caused by fungal allergy—will come back after treatment. Researchers will analyze blood samples and immune system markers to identify patients at higher risk of relapse, which could improve how doctors monitor and treat you.
Jinan, ShandongAges 18–80 - NCT06714474Recruiting
Virtual game for teaching blood draw skills to nursing students
This trial tests if a virtual simulation game helps nursing students learn how to draw blood from a vein. It may offer a new way to practice this skill before working with real patients.
Izmir, İzmirAges 18 years+ - NCT07595549RecruitingPhase 3
Testing Berobenatide for Weight Loss in Overweight Adults
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
Canoga Park, CaliforniaAges 18 years+ - NCT07596498Recruiting
Comparing two surgical approaches for severe vaginal prolapse
This study compares two minimally invasive surgical techniques to repair severe dropping of the uterus or vaginal vault (the top of the vagina). Both procedures use small cameras and instruments, and the trial aims to understand which approach works better and how quickly surgeons learn each technique.
Cairo, AbbasiaAges 40–75 - NCT07600242Recruiting
How Bilingual Children Learn Words in English and Spanish
This study looks at how children who speak both English and Spanish (or English and another language) learn new words. Researchers want to understand whether the meaning of words and how much a child hears each language affects their ability to learn.
Boston, MassachusettsAges 2 years–2.5 years - NCT07594041Recruiting
Videos for heart care education in children
This study tests whether short educational videos help caregivers of children with heart conditions understand their child's diagnosis and care plan better than standard spoken information alone.
San Antonio, TexasAges Up to 18 years - NCT07573462RecruitingPhase 3
Safety study of a new pneumococcal vaccine for infants
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
Estero, FloridaAges 1 month–3 months - NCT07569471Recruiting
Group compassion therapy for psychosis beliefs
This study tests a new group-based therapy that combines compassion-focused techniques with cognitive behavioral therapy to help people with schizophrenia or related conditions change their beliefs about their psychosis. The goal is to reduce distress and improve how you cope with symptoms.
Scarborough Village, OntarioAges 18 years+
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 596 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.